188 related articles for article (PubMed ID: 11328256)
1. Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis.
Arguedas MR; Heudebert GR; Wilcox CM
Aliment Pharmacol Ther; 2001 May; 15(5):631-8. PubMed ID: 11328256
[TBL] [Abstract][Full Text] [Related]
2. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
DuPont AW; Arguedas MR; Wilcox CM
Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
[TBL] [Abstract][Full Text] [Related]
3. Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.
Ladabaum U; Scheiman JM; Fendrick AM
Am J Med; 2003 May; 114(7):546-54. PubMed ID: 12753878
[TBL] [Abstract][Full Text] [Related]
4. Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?
Shaukat A; Parekh M; Lipscomb J; Ladabaum U
Int J Technol Assess Health Care; 2009 Apr; 25(2):222-31. PubMed ID: 19331713
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic resection is cost-effective compared with laparoscopic resection in the management of complex colon polyps: an economic analysis.
Law R; Das A; Gregory D; Komanduri S; Muthusamy R; Rastogi A; Vargo J; Wallace MB; Raju GS; Mounzer R; Klapman J; Shah J; Watson R; Wilson R; Edmundowicz SA; Wani S
Gastrointest Endosc; 2016 Jun; 83(6):1248-57. PubMed ID: 26608129
[TBL] [Abstract][Full Text] [Related]
6. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
7. Small and diminutive polyps detected at screening CT colonography: a decision analysis for referral to colonoscopy.
Pickhardt PJ; Hassan C; Laghi A; Zullo A; Kim DH; Iafrate F; Morini S
AJR Am J Roentgenol; 2008 Jan; 190(1):136-44. PubMed ID: 18094303
[TBL] [Abstract][Full Text] [Related]
8. Risk and cause of interval colorectal cancer after colonoscopic polypectomy.
Huang Y; Gong W; Su B; Zhi F; Liu S; Jiang B
Digestion; 2012; 86(2):148-54. PubMed ID: 22889865
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer.
Squires H; Tappenden P; Cooper K; Carroll C; Logan R; Hind D
Clin Ther; 2011 Sep; 33(9):1289-305. PubMed ID: 21840057
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of postpolypectomy colonoscopy surveillance using Japanese data.
Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
Dig Endosc; 2019 Jan; 31(1):40-50. PubMed ID: 30062760
[TBL] [Abstract][Full Text] [Related]
11. [Korean guidelines for post-polypectomy colonoscopic surveillance].
Hong SN; Yang DH; Kim YH; Hong SP; Shin SJ; Kim SE; Lee BI; Lee SH; Park DI; Kim HS; Yang SK; Kim HJ; Kim SH; Kim HJ;
Korean J Gastroenterol; 2012 Feb; 59(2):99-117. PubMed ID: 22387835
[TBL] [Abstract][Full Text] [Related]
12. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
Maetzel A; Krahn M; Naglie G
Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy.
McFerran E; O'Mahony JF; Fallis R; McVicar D; Zauber AG; Kee F
Epidemiol Rev; 2017 Jan; 39(1):148-160. PubMed ID: 28402402
[TBL] [Abstract][Full Text] [Related]
14. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
Pence BC; Belasco EJ; Lyford CP
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib for the prevention of colorectal adenomatous polyps.
Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.
Winawer SJ; Zauber AG; O'Brien MJ; Ho MN; Gottlieb L; Sternberg SS; Waye JD; Bond J; Schapiro M; Stewart ET
N Engl J Med; 1993 Apr; 328(13):901-6. PubMed ID: 8446136
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of small (6- to 9-mm) polyps detected at screening CT colonography: a cost-effectiveness analysis.
Pickhardt PJ; Hassan C; Laghi A; Zullo A; Kim DH; Iafrate F; Morini S
AJR Am J Roentgenol; 2008 Nov; 191(5):1509-16. PubMed ID: 18941093
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
Hur C; Simon LS; Gazelle GS
Cancer; 2004 Jul; 101(1):189-97. PubMed ID: 15222006
[TBL] [Abstract][Full Text] [Related]
20. Colonoscopic surveillance after polypectomy: considerations of cost effectiveness.
Ransohoff DF; Lang CA; Kuo HS
Ann Intern Med; 1991 Feb; 114(3):177-82. PubMed ID: 1824613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
